Human Immunoglobulin (Ph4) For Intravenous Injection (COVID-19) Market held USD 43205.8 million in 2020 and is to grow with a CAGR of 12.5% from 2020-2030.
During the COVID-19 epidemic, the Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market industry has played a critical role. To deal with the worldwide issue, traditional competitors teamed up to speed up research and develop the world's quickest new vaccine.
Харесвам
Коментирай
Сподели
